Journal article
Antigen-based vaccination and prevention of type 1 diabetes
LC Harrison, JM Wentworth, Y Zhang, E Bandala-Sanchez, RM Böhmer, AM Neale, NL Stone, G Naselli, JJ Bosco, P Auyeung, M Rashidi, P Augstein, G Morahan
Current Diabetes Reports | CURRENT MEDICINE GROUP | Published : 2013
Abstract
Insulin-dependent or type 1 diabetes (T1D) is a paradigm for prevention of autoimmune disease: Pancreatic β-cell autoantigens are defined, at-risk individuals can be identified before the onset of symptoms, and autoimmune diabetes is preventable in rodent models. Intervention in asymptomatic individuals before or after the onset of subclinical islet autoimmunity places a premium on safety, a requirement met only by lifestyle-dietary approaches or autoantigen-based vaccination to induce protective immune tolerance. Insulin is the key driver of autoimmune β-cell destruction in the nonobese diabetic (NOD) mouse model of T1D and is an early autoimmune target in children at risk for T1D. In the N..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council of Australia (Program Grant 516700; Fellowship [LCH] 637301) and was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.